# To Assess the Safety, Tolerability and Pharmacokinetics of INCB086550

> **NCT04674748** · PHASE1 · TERMINATED · sponsor: **Incyte Biosciences Japan GK** · enrollment: 3 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** INCB086550

## Key facts

- **NCT ID:** NCT04674748
- **Lead sponsor:** Incyte Biosciences Japan GK
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-02-03
- **Primary completion:** 2022-05-13
- **Final completion:** 2022-05-13
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** The study was terminated early due to a business decision.
- **Last updated:** 2025-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04674748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04674748, "To Assess the Safety, Tolerability and Pharmacokinetics of INCB086550". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04674748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*